NCT02707913View on ClinicalTrials.gov

Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Healthy
Interventions
DRUG

BF-Amlodipine Tablet 10mg

BF-Amlodipine Tablet 10mg is a generic product manufactured by Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

DRUG

Norvasc Tablet 10mg

Norvasc Tablet 10mg will be used as a comparator drug for the BE study

All Listed Sponsors
collaborator

Chinese University of Hong Kong

OTHER

lead

Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited

INDUSTRY

NCT02707913 - Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations | Biotech Hunter | Biotech Hunter